Fidelity Advisor Biotechnology Fund XENE Holdings History
Fidelity Advisor Biotechnology Fund's Xenon Pharmaceuticals Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 710,758.00 shares of Xenon Pharmaceuticals Inc(XENE), totaling $27.15 Mil. This investment constitutes 2% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.93% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.
The initial trade took place in 2020Q1. And since then Fidelity Advisor Biotechnology Fund has made 9 purchases of XENE, at an average price of $23.85, for a total of 1.43 Mil shares. In addition, there have been 3 sales at an average price of $37.91 for 715,400.00 shares. Based on historical transaction data and XENE's current price of $31.59, Fidelity Advisor Biotechnology Fund's estimated gain on his XENE holdings is $15.56 Mil, reflecting a 45.73% gain to date.
Fidelity Advisor Biotechnology Fund XENE ($31.59) Holding Chart
Fidelity Advisor Biotechnology Fund XENE ($31.59) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
